UniProt ID | TNKS1_HUMAN | |
---|---|---|
UniProt AC | O95271 | |
Protein Name | Tankyrase-1 | |
Gene Name | TNKS | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1327 | |
Subcellular Localization |
Cytoplasm. Golgi apparatus membrane Peripheral membrane protein. Chromosome, centromere. Nucleus, nuclear pore complex. Chromosome, telomere . Cytoplasm, cytoskeleton, spindle pole. Associated with the Golgi and with juxtanuclear SLC2A4/GLUT4-vesicl |
|
Protein Description | Poly-ADP-ribosyltransferase involved in various processes such as Wnt signaling pathway, telomere length and vesicle trafficking. Acts as an activator of the Wnt signaling pathway by mediating poly-ADP-ribosylation (PARsylation) of AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex: poly-ADP-ribosylated target proteins are recognized by RNF146, which mediates their ubiquitination and subsequent degradation. Also mediates PARsylation of BLZF1 and CASC3, followed by recruitment of RNF146 and subsequent ubiquitination. Mediates PARsylation of TERF1, thereby contributing to the regulation of telomere length. Involved in centrosome maturation during prometaphase by mediating PARsylation of HEPACAM2/MIKI. May also regulate vesicle trafficking and modulate the subcellular distribution of SLC2A4/GLUT4-vesicles. May be involved in spindle pole assembly through PARsylation of NUMA1. Stimulates 26S proteasome activity.. | |
Protein Sequence | MAASRRSQHHHHHHQQQLQPAPGASAPPPPPPPPLSPGLAPGTTPASPTASGLAPFASPRHGLALPEGDGSRDPPDRPRSPDPVDGTSCCSTTSTICTVAAAPVVPAVSTSSAAGVAPNPAGSGSNNSPSSSSSPTSSSSSSPSSPGSSLAESPEAAGVSSTAPLGPGAAGPGTGVPAVSGALRELLEACRNGDVSRVKRLVDAANVNAKDMAGRKSSPLHFAAGFGRKDVVEHLLQMGANVHARDDGGLIPLHNACSFGHAEVVSLLLCQGADPNARDNWNYTPLHEAAIKGKIDVCIVLLQHGADPNIRNTDGKSALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVTELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDTLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGNEAVQQILSESTPIRTSDVDYRLLEASKAGDLETVKQLCSSQNVNCRDLEGRHSTPLHFAAGYNRVSVVEYLLHHGADVHAKDKGGLVPLHNACSYGHYEVAELLVRHGASVNVADLWKFTPLHEAAAKGKYEICKLLLKHGADPTKKNRDGNTPLDLVKEGDTDIQDLLRGDAALLDAAKKGCLARVQKLCTPENINCRDTQGRNSTPLHLAAGYNNLEVAEYLLEHGADVNAQDKGGLIPLHNAASYGHVDIAALLIKYNTCVNATDKWAFTPLHEAAQKGRTQLCALLLAHGADPTMKNQEGQTPLDLATADDIRALLIDAMPPEALPTCFKPQATVVSASLISPASTPSCLSAASSIDNLTGPLAELAVGGASNAGDGAAGTERKEGEVAGLDMNISQFLKSLGLEHLRDIFETEQITLDVLADMGHEELKEIGINAYGHRHKLIKGVERLLGGQQGTNPYLTFHCVNQGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
44 | Phosphorylation | PGLAPGTTPASPTAS CCCCCCCCCCCCCCC | 23.83 | - | |
49 | Phosphorylation | GTTPASPTASGLAPF CCCCCCCCCCCCCCC | 30.84 | - | |
210 | Ubiquitination | DAANVNAKDMAGRKS HHHCCCHHHHCCCCC | 42.72 | 21890473 | |
210 | Ubiquitination | DAANVNAKDMAGRKS HHHCCCHHHHCCCCC | 42.72 | 22817900 | |
210 (in isoform 1) | Ubiquitination | - | 42.72 | 21890473 | |
210 (in isoform 2) | Ubiquitination | - | 42.72 | 21890473 | |
217 | Phosphorylation | KDMAGRKSSPLHFAA HHHCCCCCCCCHHCC | 35.51 | 21712546 | |
218 | Phosphorylation | DMAGRKSSPLHFAAG HHCCCCCCCCHHCCC | 34.22 | 25627689 | |
327 | Ubiquitination | DLADPSAKAVLTGEY HHCCCCCCHHHCCCC | 43.28 | 22817900 | |
335 | Acetylation | AVLTGEYKKDELLEA HHHCCCCCHHHHHHH | 49.82 | 19816121 | |
335 | Ubiquitination | AVLTGEYKKDELLEA HHHCCCCCHHHHHHH | 49.82 | 29967540 | |
336 | Ubiquitination | VLTGEYKKDELLEAA HHCCCCCHHHHHHHH | 56.38 | 29967540 | |
345 | Phosphorylation | ELLEAARSGNEEKLM HHHHHHHHCCHHHHH | 41.04 | 29514088 | |
350 | Ubiquitination | ARSGNEEKLMALLTP HHHCCHHHHHHHHCC | 37.07 | 29967540 | |
365 | Phosphorylation | LNVNCHASDGRKSTP CCCCCCCCCCCCCCC | 19.55 | 22817900 | |
369 | Ubiquitination | CHASDGRKSTPLHLA CCCCCCCCCCCCHHH | 65.30 | 29967540 | |
379 | Phosphorylation | PLHLAAGYNRVRIVQ CCHHHCCCCHHHHHH | 8.62 | - | |
411 | Phosphorylation | VPLHNACSYGHYEVT EECCCCCCCCCHHHH | 31.57 | 22817900 | |
412 | Phosphorylation | PLHNACSYGHYEVTE ECCCCCCCCCHHHHH | 14.06 | 22817900 | |
470 | Phosphorylation | LVNCHGKSAVDMAPT EEECCCCCCCCCCCC | 37.81 | 24144214 | |
477 | Phosphorylation | SAVDMAPTPELRERL CCCCCCCCHHHHHHH | 21.62 | 24719451 | |
489 | Ubiquitination | ERLTYEFKGHSLLQA HHHCEEECCHHHHHH | 43.72 | 32015554 | |
492 | Phosphorylation | TYEFKGHSLLQAARE CEEECCHHHHHHHHH | 39.17 | - | |
507 | Ubiquitination | ADLAKVKKTLALEII HCHHHHHHHHHHEEE | 52.32 | - | |
536 | Ubiquitination | AVASLHPKRKQVTEL HHHHHCCCHHHHHHH | 62.57 | 29967540 | |
541 | Phosphorylation | HPKRKQVTELLLRKG CCCHHHHHHHHHHCC | 20.58 | - | |
579 | Ubiquitination | DVMEVLHKHGAKMNA HHHHHHHHCCCHHHH | 39.30 | 23503661 | |
583 (in isoform 2) | Ubiquitination | - | 36.96 | - | |
583 | Ubiquitination | VLHKHGAKMNALDTL HHHHCCCHHHHHHHH | 36.96 | 32015554 | |
640 | Phosphorylation | EAVQQILSESTPIRT HHHHHHHHCCCCCCC | 31.00 | - | |
659 | Ubiquitination | YRLLEASKAGDLETV HHHHHHHCCCCHHHH | 64.53 | 33845483 | |
667 | Ubiquitination | AGDLETVKQLCSSQN CCCHHHHHHHHHCCC | 45.00 | 29967540 | |
709 | Ubiquitination | YLLHHGADVHAKDKG HHHHCCCCCCCCCCC | 37.01 | 27667366 | |
726 | Phosphorylation | VPLHNACSYGHYEVA CCCCCCCCCCCHHHH | 31.57 | - | |
727 | Phosphorylation | PLHNACSYGHYEVAE CCCCCCCCCCHHHHH | 14.06 | - | |
742 | Phosphorylation | LLVRHGASVNVADLW HHHHCCCCCCHHHHH | 20.86 | 22817900 | |
750 | Ubiquitination | VNVADLWKFTPLHEA CCHHHHHHCCHHHHH | 46.81 | - | |
760 | Ubiquitination | PLHEAAAKGKYEICK HHHHHHHCCCHHHHH | 51.73 | 32015554 | |
762 | Ubiquitination | HEAAAKGKYEICKLL HHHHHCCCHHHHHHH | 38.72 | 22817900 | |
767 (in isoform 1) | Ubiquitination | - | 48.07 | 21890473 | |
767 | Ubiquitination | KGKYEICKLLLKHGA CCCHHHHHHHHHCCC | 48.07 | 21890473 | |
767 | Ubiquitination | KGKYEICKLLLKHGA CCCHHHHHHHHHCCC | 48.07 | 22817900 | |
771 | Ubiquitination | EICKLLLKHGADPTK HHHHHHHHCCCCCCC | 39.71 | 22817900 | |
777 | Phosphorylation | LKHGADPTKKNRDGN HHCCCCCCCCCCCCC | 56.02 | - | |
778 | Acetylation | KHGADPTKKNRDGNT HCCCCCCCCCCCCCC | 54.13 | 11925781 | |
779 | Acetylation | HGADPTKKNRDGNTP CCCCCCCCCCCCCCC | 60.74 | 11925791 | |
791 | Ubiquitination | NTPLDLVKEGDTDIQ CCCHHHHHCCCCCHH | 64.38 | 32015554 | |
812 | Ubiquitination | AALLDAAKKGCLARV HHHHHHHHHCHHHHH | 51.96 | - | |
813 | Ubiquitination | ALLDAAKKGCLARVQ HHHHHHHHCHHHHHH | 50.56 | 27667366 | |
821 | Ubiquitination | GCLARVQKLCTPENI CHHHHHHHHCCCCCC | 42.55 | 32015554 | |
839 | Phosphorylation | DTQGRNSTPLHLAAG CCCCCCCCCCEEECC | 33.16 | 21818122 | |
901 | Ubiquitination | TCVNATDKWAFTPLH CCCCCCCCCCCCHHH | 35.75 | 29967540 | |
916 | Phosphorylation | EAAQKGRTQLCALLL HHHHCCHHHHHHHHH | 34.26 | - | |
930 | Phosphorylation | LAHGADPTMKNQEGQ HHCCCCCCCCCCCCC | 41.13 | 21818122 | |
932 | Ubiquitination | HGADPTMKNQEGQTP CCCCCCCCCCCCCCC | 58.94 | - | |
978 | Phosphorylation | VVSASLISPASTPSC EEEEHHCCCCCCHHH | 21.51 | 22817900 | |
982 | Phosphorylation | SLISPASTPSCLSAA HHCCCCCCHHHHHHH | 22.71 | 22817900 | |
987 | Phosphorylation | ASTPSCLSAASSIDN CCCHHHHHHHHHCCC | 26.56 | 22817900 | |
991 | Phosphorylation | SCLSAASSIDNLTGP HHHHHHHHCCCCCCC | 29.27 | 22817900 | |
1020 | Ubiquitination | GAAGTERKEGEVAGL CCCCCCCCCCCCCCC | 64.93 | - | |
1081 | Ubiquitination | GHRHKLIKGVERLLG CHHHHHHHHHHHHHC | 68.30 | - | |
1128 | Phosphorylation | VEEEMQSTIREHRDG HHHHHHHHHHHHCCC | 13.73 | 21818122 | |
1152 | Ubiquitination | YNVIRIQKVVNKKLR HCHHHHHHHHCHHHH | 45.86 | 29967540 | |
1167 | Ubiquitination | ERFCHRQKEVSEENH HHHHHCHHCCCCCCC | 61.10 | 29967540 | |
1195 | Ubiquitination | FINAIIHKGFDERHA HHHHHHHCCCCHHCC | 51.36 | 32015554 | |
1238 | Ubiquitination | GTGCPTHKDRSCYIC CCCCCCCCCCCEEEE | 58.26 | - | |
1258 | Ubiquitination | FCRVTLGKSFLQFST HCHHHCCCCHHHHHH | 40.94 | - | |
1289 | Phosphorylation | PSVNGLAYAEYVIYR CCCCCEEEEEEEEEC | 12.66 | - | |
1292 | Phosphorylation | NGLAYAEYVIYRGEQ CCEEEEEEEEECCCC | 5.51 | 22817900 | |
1308 | Phosphorylation | YPEYLITYQIMKPEA CCEEEEEEEECCCCC | 6.77 | 24260401 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
839 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
930 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
978 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
978 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
982 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
982 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
987 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
991 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
1128 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF146 | Q9NTX7 | PMID:21478859 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNKS1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNKS1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TERF1_HUMAN | TERF1 | physical | 11739745 | |
TB182_HUMAN | TNKS1BP1 | physical | 11854288 | |
TERF1_HUMAN | TERF1 | physical | 11854288 | |
TNKS1_HUMAN | TNKS | physical | 9822378 | |
TERF1_HUMAN | TERF1 | physical | 9822378 | |
FACD2_HUMAN | FANCD2 | physical | 21314979 | |
GMDS_HUMAN | GMDS | physical | 22645305 | |
TINF2_HUMAN | TINF2 | physical | 15133513 | |
TERF1_HUMAN | TERF1 | physical | 15133513 | |
TNKS1_HUMAN | TNKS | physical | 15133513 | |
AXIN1_HUMAN | AXIN1 | physical | 25547115 | |
PTEN_HUMAN | PTEN | physical | 25547115 | |
TNKS1_HUMAN | TNKS | physical | 25547115 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND MASSSPECTROMETRY. |